Combined Methylome and Transcriptome Analyses Reveals Potential Therapeutic Targets for EGFR Wild Type Lung Cancers with Low PD-L1 Expression

SIMPLE SUMMARY: Low expression of programmed death-ligand 1 (PD-L1), epidermal growth factor receptor (EGFR) wild-type non-small cell lung cancer (NSCLCs) are refractory, and only few therapeutic options exist. This study aims to clarify the molecular basis of this special subtype of NSCLC and ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Weilei, Wang, Guosheng, Yarmus, Lonny B., Wan, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563876/
https://www.ncbi.nlm.nih.gov/pubmed/32899191
http://dx.doi.org/10.3390/cancers12092496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563876/
https://www.ncbi.nlm.nih.gov/pubmed/32899191
http://dx.doi.org/10.3390/cancers12092496

Ejemplares similares